NCT02007200 · OUTCOME
The Number of Participants Alive at Follow-up
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- participants
- Interval / dispersion
- Not reported
- Time frame
- Up to 24 months
What was measured
Overall survival at last follow-up will be determined.
Analysis population: 55 patients were enrolled. 3 patients did not undergo treatment. 13 patients had insufficient tissue and were therefore not evaluable. Only the 39 evaluable patients were included in the analysis.
Groups in this outcome
Treatment (Soy Isoflavones)
Patients receive soy isoflavones PO for approximately 14 days before undergoing surgery.
| Group | Source count |
|---|---|
| Treatment (Soy Isoflavones) | 39 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Treatment (Soy Isoflavones) | 29 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 29
- denoms
- counts
- group Id
- OG000
- value
- 39
- units
- Participants
- description
- Overall survival at last follow-up will be determined.
- groups
- description
- Patients receive soy isoflavones PO for approximately 14 days before undergoing surgery.
- id
- OG000
- title
- Treatment (Soy Isoflavones)
- param Type
- NUMBER
- population Description
- 55 patients were enrolled. 3 patients did not undergo treatment. 13 patients had insufficient tissue and were therefore not evaluable. Only the 39 evaluable patients were included in the analysis.
- reporting Status
- POSTED
- time Frame
- Up to 24 months
- title
- The Number of Participants Alive at Follow-up
- type
- SECONDARY
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle